Group Cognitive Behavioural Therapy for Adults With Cystic Fibrosis

Brief summary (registry, in English)

The overall goal of this clinical trial is to: a) explore the feasibility, acceptability, and participant experiences with the group version of CF-CBT; b) examine the effectiveness of the virtual delivery of a group version of CF-CBT in reducing depression and anxiety symptoms, perceived stress, coping skills, and health related quality of life among adults with CF. The primary research questions is: • How feasible and acceptable (i.e., drop out, adherence, and satisfaction) is virtual, group CF-CBT? The secondary research questions is: • How will virtual, group CF-CBT affect depression and anxiety? The tertiary/other research questions are: * How will virtual, group CF-CBT affect perceived stress, coping skills, and health related quality of life? * What is the association between group cohesion and depression, anxiety, perceived stress, coping skills, and health related quality of life? Participants will: * Complete short demographic questionnaire regarding their personal and health information. * Complete questionnaires about symptoms of depression, anxiety, perceived stress, coping skills, and health related quality of life at pre- and post-program. An additional measure of treatment expectancy will be completed at pre-program only. At post-program only, measures of group cohesion and treatment satisfaction will be completed. * Complete the CF-CBT online mental health program over eight weeks. * Be invited to complete an interview about their experiences with the program. Primary outcomes will be compared to benchmark study of individual CF-CBT. Secondary outcomes (i.e., depression, anxiety) will be compared against themselves (i.e., pre- and post-group). Tertiary/other outcomes (i.e., perceived stress, coping skills, health related quality of life) will be compared against themselves (i.e., pre- and post-group). The associations between self-reported outcome measures and group cohesion will be analyzed by computing Pearson correlation coefficients.

What you commit to

• Study type: Interventional
• Participants enrolled: 21
• From 1 Oct 2024 to the primary completion date, 30 Jun 2025
• 2 sites in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.